Intra-Cellular Therapies, Inc. - ITCI

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 12/20/2024 10:22:22 PM
EDGAR CIK 0001567514

Buy Breakdown

Total $0

Sell Breakdown

Total $5,016,172

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
02/02/2024
10b5-1
02/05/2024
Durgam Suresh K.
EVP, Chief Medical Officer
Officer
Sell
-6,167 @ $67.19
($414,354.83)
 5,693 (-52.00%) Direct
02/02/2024
10b5-1
02/05/2024
Halstead Michael
EVP and General Counsel
Officer
Sell
-11,860 @ $66.42
($787,719.40)
 0 (-100.00%) Direct
02/02/2024
10b5-1
02/05/2024
Hineline Lawrence J.
SVP of Finance, CFO
CFO
Sell
-11,183 @ $66.62
($745,036.53)
 0 (-100.00%) Direct
02/02/2024
10b5-1
02/05/2024
Mates Sharon
Chairman, President & CEO
CEO Director
Sell
-33,885 @ $67.07
($2,272,693.50)
 1,050,309 (-3.13%) Direct
02/02/2024
10b5-1
02/05/2024
Neumann Mark
EVP, Chief Commercial Officer
Officer
Sell
-11,860 @ $67.15
($796,367.48)
 29,700 (-28.54%) Direct